Haleon Spon Ads Each Rep 2 Ord Shs (HLN) Stock
Publicly traded company. Here's the price, business snapshot, and what's worth knowing about Haleon Spon Ads Each Rep 2 Ord Shs in October 2026.
Haleon plc is a consumer healthcare company. The Company’s product portfolio spans six major categories, including oral health, vitamins, minerals and supplements (VMS), pain relief, respiratory health, digestive health and therapeutic skin health and others. The Company's segments include North America, Europe, Asia Pacific, and International. Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company’s oral health brands include Sensodyne, Polident, and Parodontax. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, Flonase, Contac, and Beechams. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Benefiber. Its therapeutic skin health brands include Fenistil, Zovirax, and Bactroban.
Haleon Spon Ads Each Rep 2 Ord Shs (HLN) Stock Forecast
Analyst price target, next 12 months
$10.86
+16.5% vs today's $9.32
Price range over the last 12 months
In the middle of its 12-month range
Analysts covering Haleon Spon Ads Each Rep 2 Ord Shs have a consensus 12-month target of $10.86, above the current price of $9.32.
Analyst targets are opinions, not guarantees. Capital at risk. Data as of 11 Oct 2026.
Source: Analyst sentiment is provided by Refinitiv Ltd, a global leader in financial market data with over 40k business clients. Refinitiv Ltd is an independent third party to Nemo. This is not advice.
Sixth Month Growth Performance
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Haleon's stock, expecting its value to rise to $10.86.
Financial Health
Haleon is performing well with strong revenue and profits, showing good overall financial stability.
Dividend
Haleon's below average dividend yield of 1.6% suggests limited returns for investors seeking income. If you invested $1000 you would be paid $16 a year in dividends (based on the last 12 months).
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
